Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has reached a 52-week low, trading at $9.1, reflecting a period of significant pressure for the biopharmaceutical company. With a market ...

CRB Classical Radio Boston is a non-commercial, independent, listener-supported public radio station dedicated to excellence in classical music broadcasting and to finding ways to expand the audience ...

The new $1 billion mill is expected to consume 20,000 tons of OCC per month and produce 1,500 tons per day of CRB. Graphic Packaging's new $1 billion mill is expected to consume 20,000 tons of OCC per ...